ArticleCancer discovery2025

A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma.

Caroline Broderick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.